The impact of the perception of treatment choice on satisfaction with treatment, experienced chemotherapy burden and current quality of life

被引:0
|
作者
S J T Jansen
W Otten
C J H van de Velde
J W R Nortier
A M Stiggelbout
机构
[1] J10S,Department of Medical Decision Making
[2] Leiden University Medical Center,undefined
来源
British Journal of Cancer | 2004年 / 91卷
关键词
quality of life; treatment choice; cancer; adjuvant chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
Previous research has shown that involving patients in the decision-making process may improve their quality of life (QoL). Our purposes were to assess: (1) whether early-stage breast cancer patients perceived that they had treatment choice with regard to adjuvant chemotherapy, (2) what reasons patients provide for their perception of having had no choice of treatment and (3) whether the perception of treatment choice is related to satisfaction with the assigned treatment, experienced chemotherapy burden and current QoL. A total of 448 patients, treated between 1998 and 2003, filled in the questionnaire (response rate: 62%). Patients who indicated that they had not perceived a choice regarding chemotherapy could tick off one or more reasons out of 10 reasons, or provide their own reason(s). Quality of life was measured on a Visual Analogue Scale, by means of the EuroQol, and by means of the Hospital Anxiety and Depression Scale. Of the 405 patients who had answered the question on treatment choice, 316 patients (78%) had perceived no choice. The most frequently indicated reason for lack of choice was: ‘I follow the doctor's advice.’ We found no differences in the levels of satisfaction with assigned treatment and in how much of a burden they found chemotherapy between patients who perceived a choice of treatment and those who did not. In general, the perception of choice seemed to have no impact on QoL. However, we found an interaction effect, which indicated that the impact of perception of treatment choice on QoL was dependent upon whether the patient had been treated with chemotherapy or not. Within the group of patients who had not been treated with chemotherapy, the perception of having had a choice was related to lower current QoL. In cases when the decision to be treated or not has potential consequences for the chance of survival, patients' QoL may not be improved by the perception of having had a choice of treatment.
引用
收藏
页码:56 / 61
页数:5
相关论文
共 50 条
  • [1] The impact of the perception of treatment choice on satisfaction with treatment, experienced chemotherapy burden and current quality of life
    Jansen, SJT
    Otten, W
    van de Velde, CJH
    Nortier, JWR
    Stiggelbout, AM
    BRITISH JOURNAL OF CANCER, 2004, 91 (01) : 56 - 61
  • [2] The impact of perceived freedom of treatment choice on current quality of life, experienced treatment difficulty, and satisfaction with assigned treatment?
    Jansen, SJT
    Stiggelbout, AM
    Otten, W
    PSYCHO-ONCOLOGY, 2003, 12 (08) : 837 - 838
  • [3] Treatment choice, satisfaction and quality of life in patients with Graves' disease
    Conaglen, Helen M.
    Tamatea, Jade A. U.
    Conaglen, John, V
    Elston, Marianne S.
    CLINICAL ENDOCRINOLOGY, 2018, 88 (06) : 977 - 984
  • [4] Impact of treatment satisfaction on quality of life of patients with acromegaly
    Hasan Kepicoglu
    Esra Hatipoglu
    Irem Bulut
    Ezgi Darici
    Naz Hizli
    Pinar Kadioglu
    Pituitary, 2014, 17 : 557 - 563
  • [5] Impact of treatment satisfaction on quality of life of patients with acromegaly
    Kepicoglu, Hasan
    Hatipoglu, Esra
    Bulut, Irem
    Darici, Ezgi
    Hizli, Naz
    Kadioglu, Pinar
    PITUITARY, 2014, 17 (06) : 557 - 563
  • [6] Chemotherapy-induced Emesis: Experienced Burden in Life, and Significance of Treatment Expectations and Communication in Chemotherapy Care
    Widgren, Ylva
    Silen, Marit
    Wahlin, Ingrid
    Lindberg, Magnus
    Fransson, Per
    Efverman, Anna
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [7] Quality of Life, Risk Perception, and Treatment Burden with Peanut Oral Immunotherapy
    LeBovidge, Jennifer S.
    Rachid, Rima A.
    MacGinnitie, Andrew
    Secor, William
    Burke-Roberts, Elizabeth S.
    Pongracic, Jacqueline A.
    Spergel, Jonathan M.
    Nadeau, Kari
    Umetsu, Dale T.
    Schneider, Lynda C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB133 - AB133
  • [8] Impact of chemotherapy treatment on the quality of life of patients with cancer
    Silveira, Fernanda Modesto
    Wysocki, Anneliese Domingues
    Mendez, Roberto Della Rosa
    Pena, Silvana Barbosa
    dos Santos, Edirlei Machado
    Malaguti-Toffano, Silmara
    dos Santos, Vinicius Batista
    dos Santos, Mariana Alvina
    ACTA PAULISTA DE ENFERMAGEM, 2021, 34
  • [9] Burden and quality of life of caregivers of children and adolescents with chemotherapy treatment for cancer
    Rubira, Elizete Aparecida
    Marcon, Samira Reschetti
    Silva Belasco, Angelica Goncalves
    Munhoz Gaiva, Maria Aparecida
    Espinosa, Mariano Martinez
    ACTA PAULISTA DE ENFERMAGEM, 2012, 25 (04) : 567 - 573
  • [10] FABRY DISEASE: SYMPTOM BURDEN, HEALTH-RELATED QUALITY OF LIFE BURDEN AND TREATMENT SATISFACTION
    Gallop, K.
    Lloyd, A.
    MacCulloch, A.
    Nordin, S.
    VALUE IN HEALTH, 2022, 25 (01) : S213 - S213